Optune® is an FDA-approved treatment for adults with newly diagnosed or recurrent glioblastoma (GBM) offered by our Brain & Spine Tumor Program. It is a portable, noninvasive device that you can use continuously at home, work, school or anywhere else you need to go.
Transducer arrays are attached to the scalp and connected to a system that delivers alternating electric fields to the brain. These fields target and disrupt the dividing cancer cells, causing them to die while leaving the healthy brain cells untouched.
The system comes with four battery packs — allowing you to move freely while you go about your daily routine. When you are sleeping or relaxing, you can plug the unit into a wall outlet. The entire unit fits into a small case that can be worn as a backpack or over the shoulder.
In addition to the freedom it affords, Optune does not have the same side effects as chemotherapy or other treatment options. As a result, patients using Optune reported a better quality of life while undergoing treatment.
Learn More About Optune
Watch these manufacturer videos to learn more about how the Optune system works and how it made a difference in patients' lives.
Virtual Visits Are Available
Safe and convenient virtual visits by video let you get the care you need via a mobile device, tablet or computer wherever you are. We’ll gather your medical records for you and get our experts’ input so we can offer treatment options without an in-person visit. To schedule a virtual visit, call 1-866-680-0505.
Cancer and the COVID-19 Vaccine
There is currently no data that suggests current or former cancer patients should avoid getting the COVID-19 vaccine. Cancer can weaken your immune system, so we recommend that most patients get the vaccine as soon as possible.